PWLP
IBB icon

Prio Wealth Limited Partnership’s iShares Biotechnology ETF IBB Stock Holding History

Prio Wealth Limited Partnership’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,895
Closed -$248K – 244
2016
Q2 		$248K Hold
2,895
– – 0.01% 226
2016
Q1 		$251K Hold
2,895
– – 0.01% 224
2015
Q4 		$326K Buy
2,895
+330
+13% +$35.8K 0.02% 203
2015
Q3 		$259K Sell
2,565
-210
-8% -$25.2K 0.01% 222
2015
Q2 		$341K Buy
2,775
+210
+8% +$25.1K 0.02% 207
2015
Q1 		$293K Buy
2,565
+210
+9% +$23.2K 0.01% 217
2014
Q4 		$238K Buy
+2,355
New +$229K 0.01% 236

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Prio Wealth Limited Partnership's IBB Position: Q3 2016 in Review

Prio Wealth Limited Partnership sold out of iShares Biotechnology ETF (IBB) in Q3 2016, closing a stake of 2,895 shares — an estimated $248K sold.

Prio Wealth Limited Partnership first reported a position in IBB in Q4 2014 and held it in 7 quarters. The position peaked at $341K in Q2 2015. 464 funds tracked by Wall St. Rank hold IBB as of Q3 2016.

  • Prio Wealth Limited Partnership reported no remaining iShares Biotechnology ETF position as of Q3 2016 after selling out during the quarter.
  • Prio Wealth Limited Partnership sold 2,895 iShares Biotechnology ETF shares in Q3 2016, an estimated $248K.
  • Prio Wealth Limited Partnership first reported a position in iShares Biotechnology ETF in Q4 2014 and held it in 7 quarters.
  • Prio Wealth Limited Partnership's iShares Biotechnology ETF position peaked at $341K in Q2 2015.
  • 464 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2016.

Based on Prio Wealth Limited Partnership's 13F filing for Q3 2016, filed 25 Oct 2016.